JP2023522987A5 - - Google Patents
Info
- Publication number
- JP2023522987A5 JP2023522987A5 JP2022564247A JP2022564247A JP2023522987A5 JP 2023522987 A5 JP2023522987 A5 JP 2023522987A5 JP 2022564247 A JP2022564247 A JP 2022564247A JP 2022564247 A JP2022564247 A JP 2022564247A JP 2023522987 A5 JP2023522987 A5 JP 2023522987A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- bupivacaine
- stable
- free base
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024068119A JP2024091835A (ja) | 2020-04-22 | 2024-04-19 | 持続性ブピバカインマイクロスフェア製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063013736P | 2020-04-22 | 2020-04-22 | |
| US63/013,736 | 2020-04-22 | ||
| PCT/US2021/028718 WO2021216928A1 (en) | 2020-04-22 | 2021-04-22 | Long-acting bupivacaine microsphere formulations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024068119A Division JP2024091835A (ja) | 2020-04-22 | 2024-04-19 | 持続性ブピバカインマイクロスフェア製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023522987A JP2023522987A (ja) | 2023-06-01 |
| JP2023522987A5 true JP2023522987A5 (cg-RX-API-DMAC7.html) | 2024-05-01 |
Family
ID=78270085
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022564247A Withdrawn JP2023522987A (ja) | 2020-04-22 | 2021-04-22 | 持続性ブピバカインマイクロスフェア製剤 |
| JP2024068119A Pending JP2024091835A (ja) | 2020-04-22 | 2024-04-19 | 持続性ブピバカインマイクロスフェア製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024068119A Pending JP2024091835A (ja) | 2020-04-22 | 2024-04-19 | 持続性ブピバカインマイクロスフェア製剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240033221A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4138783B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023522987A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3180971A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021216928A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025015011A1 (en) * | 2023-07-10 | 2025-01-16 | Nevakar Injectables Inc. | Bupivacaine compositions and methods |
| US12648940B2 (en) | 2023-09-12 | 2026-06-09 | Fresenius Kabi Austria Gmbh | Bupivacaine liquid formulations |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5466468A (en) | 1990-04-03 | 1995-11-14 | Ciba-Geigy Corporation | Parenterally administrable liposome formulation comprising synthetic lipids |
| US5922340A (en) * | 1992-09-10 | 1999-07-13 | Children's Medical Center Corporation | High load formulations and methods for providing prolonged local anesthesia |
| EP1014953B1 (en) * | 1997-03-05 | 2012-04-25 | Sugen, Inc. | Formulations for hydrophobic pharmaceutical agents |
| US6383168B1 (en) * | 1998-12-08 | 2002-05-07 | Bioject Medical Technologies Inc. | Needleless syringe with prefilled cartridge |
| US20030152637A1 (en) * | 2001-01-25 | 2003-08-14 | Mark Chasin | Local anesthetic, and method of use |
| EP1555278A1 (en) | 2004-01-15 | 2005-07-20 | Innocore Technologies B.V. | Biodegradable multi-block co-polymers |
| US9132085B2 (en) * | 2008-04-18 | 2015-09-15 | Warsaw Orthopedic, Inc. | Compositions and methods for treating post-operative pain using clonidine and bupivacaine |
| CA2842514C (en) | 2011-07-22 | 2018-12-18 | Innocore Technologies B.V. | Biodegradable, semi-crystalline, phase separated, thermoplastic multi-block copolymers for controlled release of biologically active compounds |
| EP2968762B1 (en) * | 2013-03-15 | 2021-04-21 | Hyprotek, Inc. | Multi-chamber injection device |
| US10449152B2 (en) * | 2014-09-26 | 2019-10-22 | Covidien Lp | Drug loaded microspheres for post-operative chronic pain |
| KR102047983B1 (ko) * | 2017-11-30 | 2019-11-22 | 주식회사 지투지바이오 | 안전성 및 저장 안정성이 향상된 생분해성 미립구의 제조방법 |
| AU2019328276B2 (en) * | 2018-08-31 | 2025-07-03 | Rilento Pharma, Llc | Pharmaceutical formulation and system and method for delivery |
| BR112021006406A2 (pt) | 2018-10-02 | 2021-07-06 | Innocore Tech Holding B V | forma de dosagem de gonadotrofina coriônica humana (hcg) de liberação prolongada |
| CA3156256A1 (en) | 2019-10-01 | 2021-04-08 | InnoCore Technologies Holding B.V. | Biodegradable, phase separated, thermoplastic multi-block copolymer |
-
2021
- 2021-04-22 CA CA3180971A patent/CA3180971A1/en active Pending
- 2021-04-22 JP JP2022564247A patent/JP2023522987A/ja not_active Withdrawn
- 2021-04-22 US US17/996,995 patent/US20240033221A1/en active Pending
- 2021-04-22 EP EP21793476.9A patent/EP4138783B1/en active Active
- 2021-04-22 WO PCT/US2021/028718 patent/WO2021216928A1/en not_active Ceased
-
2024
- 2024-04-19 JP JP2024068119A patent/JP2024091835A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230091533A1 (en) | Biodegradable drug delivery compositions | |
| JP5951991B2 (ja) | 医薬組成物 | |
| EP3655017B1 (en) | Pharmaceutical composition | |
| EP1758553B1 (en) | Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons | |
| US20180214507A1 (en) | COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS | |
| BR9914258B1 (pt) | Polímero triboloco biodegradável e composição polimérica aquosa biodegradável | |
| JP2024091835A (ja) | 持続性ブピバカインマイクロスフェア製剤 | |
| JP2023522134A5 (cg-RX-API-DMAC7.html) | ||
| RU2789057C2 (ru) | КОМПОЗИЦИИ И СПОСОБЫ ДЛИТЕЛЬНОГО ВЫСВОБОЖДЕНИЯ АНТАГОНИСТОВ ГОНАДОТРОПИН-ВЫСВОБОЖДАЮЩЕГО ГОРМОНА (GnRH) | |
| EP2172189A1 (en) | Pharmaceutical Compositions | |
| US20200282008A1 (en) | COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS | |
| HK40074403A (en) | Compositions and methods for long term release of gonadotropin-releasing hormone (gnrh) antagonists | |
| WO2021237039A1 (en) | Compositions and methods for long term release of gonadotropin-releasing hormone (gnrh) antagonists | |
| EP2213307A1 (en) | Injectable depot formulations | |
| HK1248146A1 (en) | Biodegradable drug delivery compositions |